Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I/II trial studies the side effects and best dose of gefitinib when given together
with radiation therapy and to see how well it works in treating patients with glioblastoma
multiforme. Gefitinib may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth. Radiation therapy uses high energy x rays to kill tumor cells. Giving
gefitinib together with radiation therapy may be an effective treatment for glioblastoma
multiforme.